Evidence map›Paper›PMID 19318463›Full record

ArticleRNA (New York, N.Y.)2009

Differential functions of two editosome exoUases in Trypanosoma brucei.

Nancy Lewis Ernst, Brian Panicucci, Jason Carnes, Kenneth Stuart

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. KRGG1 function in RNA editing inRNA (New York, N.Y.) · 2023
    Article
  4. How RNases Shape Mitochondrial Transcriptomes.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. The Architecture of Trypanosoma brucei editosomes.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens.International journal for parasitology. Drugs and drug resistance · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nancy Lewis ErnstSeattle Biomedical Research Institute, Seattle, Washington 98109, USA.
Brian Panicucci
Jason Carnes
Kenneth Stuart
Center for Infectious Disease Research · US

Funding

MITOCHONDRIAL DNA OF NORMAL AND MUTANT TRYPANOSOMESR01AI014102 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KENNETH D STUART · 1985 to 2026
$20.9M
MITOCHONDRIAL DNA OF NORMAL AND MUTANT TRYPANOSOMESR37AI014102 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI STUART, KENNETH D · 1992 to 2001
$971k
NIAID NIH HHS AI14102NIAID NIH HHS R01 AI014102NIAID NIH HHS R37 AI014102
6 · The paper itself

Abstract

Mitochondrial RNAs in trypanosomes are edited by the insertion and deletion of uridine (U) nucleotides to form translatable mRNAs. Editing is catalyzed by three distinct editosomes that contain two related U-specific exonucleases (exoUases), KREX1 and KREX2, with the former present exclusively in KREN1 editosomes and the latter present in all editosomes. We show here that repression of KREX1 expression leads to a concomitant reduction of KREN1 in approximately 20S editosomes, whereas KREX2 repression results in reductions of KREPA2 and KREL1 in approximately 20S editosomes. Knockdown of KREX1 results in reduced cell viability, reduction of some edited RNA in vivo, and a significant reduction in deletion but not insertion endonuclease activity in vitro. In contrast, KREX2 knockdown does not affect cell growth or editing in vivo but results in modest reductions of both insertion and deletion endonuclease activities and a significant reduction of U removal in vitro. Simultaneous knockdown of both proteins leads to a more severe inhibition of cell growth and editing in vivo and an additive effect on endonuclease cleavage in vitro. Taken together, these results indicate that both KREX1 and KREX2 are important for retention of other proteins in editosomes, and suggest that the reduction in cell viability upon KREX1 knockdown is likely a consequence of KREN1 loss. Furthermore, although KREX2 appears dispensable for cell growth, the increased inhibition of editing and parasite viability upon knockdown of both KREX1 and KREX2 together suggests that both proteins have roles in editing.

Indexed as

RNA EditingAnimalsExonucleasesGene Knockdown TechniquesRNA InterferenceTrypanosoma brucei bruceiUridineExonucleasesUridine

Identifiers

PMID19318463
PMCPMC2673068
OpenAlexW2171910259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.